Anti-BTN2A2/BTF2 antibody [4B11C8]
Be the first to review this product! Submit a review
|
(2 Publications )
Image updates are in progress. Products remain available and covered by the Abcam Product Promise. Learn more.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-BTN2A2/BTF2 antibody [4B11C8] (AB233752)
Flow cytometric analysis of HeLa (human epithelial cell line from cervix adenocarcinoma) cell line labeling BTN2A2/BTF2 with ab233752 at 1/200 dilution (green) compared with a negative control (red).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-BTN2A2/BTF2 antibody [4B11C8] (AB233752)
HeLa (human prostate adenocarcinoma cell line) cells stained for BTN2A2/BTF2 (green) using ab233752 at 1/200 dilution in ICC/IF.
Blue : DRAQ5 fluorescent DNA dye. Red : Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
BTN2A2/BTF2 modulates T cell activity helping to maintain immune tolerance and preventing overactive immune responses. It functions as part of a larger complex that includes various other immunoregulatory proteins. This complex is critical for fine-tuning immune responses by affecting T cell proliferation and cytokine production. Without proper regulation by BTN2A2 there can be an increased risk of autoimmunity and immune dysregulation.
Pathways
BTN2A2/BTF2 involvement is essential within the immune checkpoint pathways particularly those influencing T cell regulation. It interacts closely with the PD-1 pathway which is significant in mediating immune inhibitory signals. Furthermore BTN2A2 has relationships with other proteins in these pathways such as CTLA-4 which is another key player in maintaining immune balance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Publications (2)
Recent publications for all applications. Explore the full listand refine your search
Frontiers in oncology 12:816760 PubMed36033440
2022
Applications
Unspecified application
Species
Unspecified reactive species
Clinical cancer research : an official journal of the American Association for Cancer Research 28:2020-2029 PubMed35165101
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com